Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide (NO) Homeostasis

• Status: Completed
• Trial end date: 2013-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to explore the impact of aged blood on endothelial function by measuring forearm blood flow during intra-arterial acetylcholine infusion in normal healthy human volunteers after infusion of autologous blood stored for 5-10 days or 35-42 days.

Our hypothesis is that 1) the vasodilatory response to the infusion of acetylcholine will be reduced in the 35-42 day group compared with the 5-10 day group, because of scavenging of the NO released from the endothelium by the hemolytic process in the aged blood, 2) that the infusion of aged stored blood will produce vasoconstriction, measured by reduced forearm blood flow during infusion of the 35-42 day compared with the 5-10 day old blood, and that 3) there will be increases in venous levels of cell free plasma hemoglobin, red cell microparticles, red cell membrane damage, arginase levels and activity, decreased arginine levels, markers of oxidative stress (carbamylated proteins and nitrated tyrosine residues), and increases in plasma in vitro NO consumption during the infusion of 35-42 day old compared to 5-10 day old blood.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Mark Gladwin
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Acetylcholine; Nitric Oxide

Criteria

Inclusion Criteria:

• Male or female and 18 to 50 years of age.

• Able to read and comprehend the English language

Exclusion Criteria:

• Less than 18 or greater than 50 years of age.

• Female < 110 lbs or 50 kg

• Male < 110 lbs or 50 kg

• Hemoglobin <12.5g/dl

• Past medical history or symptoms of blood dyscrasia, diabetes mellitus, hyperlipidemia, obstructive sleep apnea, hypertension, significant cardiac disease and / or known peripheral arterial disease.

• History of cigarette smoking within the last month

• Serum creatinine >1.0 mg/dL

• Cognitively impaired subjects, or institutionalized persons and subjects unable or unwilling to complete written informed consent (no proxy consent will be obtained)

• Subjects with a history of blood donation within the last 60 days.

• Subjects who have performed other medical studies involving drug delivery in the last 30 days.

• Subjects with an oxygen saturation value < 92%.

• Any STATIN drug (Fluvastatin, Lovastatin, Pravastatin, Simvastatin, Rosuvastatin) currently or in the 4 weeks prior to the screening day

• Any medication for the treatment of diabetes including oral hypoglycemics or insulin

• lab tests indicating blood dyscrasia, diabetes, hypertension or hypercholesterolemia.Females of childbearing potential who are pregnant or unwilling to undergo pregnancy testing; females with positive pregnancy testing on screening day will be excluded